Andrew D. Hopper

Andrew D. Hopper

Auto-generated profile, based on publicly available information

Andrew D. Hopper

Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2007 in Endoscopy
Verified
Journal Article
Closed access
AHA. D. Hopper
A. D. Hopper
SCSimon Cross
Simon Cross
DSD. S. Sanders
D. S. Sanders
Background and study aims: The current internationally accepted gold standard for diagnosing celiac disease is a small-bowel biopsy demonstrating villous atrophy. However, it has been suggested that the diagnosis might not be considered as confirmed if the villous atrophy is patchy. Our aim was to assess whether there is an optimal duodenal biopsy strategy for detecting villous atrophy in adult patients with suspected gluten-sensitive enteropathy. Patients and methods: Patients who had positive endomysial or tissue transglutaminase antibodies were prospectively recruited. Nine biopsies were taken from the duodenum: one from the duodenal bulb, four from the proximal duodenum, and four from the distal duodenum. Each biopsy was graded according to the Marsh criteria. All possible biopsy regimes were evaluated for their ability to detect the presence and severity of villous atrophy. Results: A total of 56 patients were recruited (23 men [41 %], 33 women [59 %]; mean age 47, range 16 - 85): 53/56 patients had villous atrophy present in at least one biopsy; 10/53 patients had biopsy specimens that showed ”patchy” villous atrophy. In all 53 patients with villous atrophy this was detected by taking a minimum of three biopsies (sensitivity 100 %, 95 % confidence interval [CI] 93.2 % - 100 %). However, this strategy always incorporated a duodenal bulb biopsy. The most severe degree of villous atrophy in all 56 patients was only detected by using a five-biopsy regime (sensitivity 100 %, 95 % CI 93.6 % - 100 %). Conclusions: In this study we observed that villous atrophy in adult patients with suspected gluten-sensitive enteropathy (antibody-positive) is patchy. For this reason we would suggest a minimum of three biopsies, incorporating a duodenal bulb biopsy, to ensure that villous atrophy is detected. However, a five-biopsy regime is required for recognition of the most severe lesion.

23 March 2007 in BMJ
Verified
Journal Article
Closed access
PDF file
AHAndrew D Hopper
Andrew D Hopper
SCSimon Cross
Simon Cross
DHDavid P Hurlstone
David P Hurlstone
MMMark E McAlindon
Mark E McAlindon
ALAlan J Lobo
Alan J Lobo
DSDavid S Sanders
David S Sanders
Objective To determine an effective diagnostic method of detecting all cases of coeliac disease in patients referred for gastroscopy without performing routine duodenal biopsy. Design An initial retrospective cohort of patients attending for gastroscopy was analysed to derive a clinical decision tool that could increase the detection of coeliac disease without performing routine duodenal biopsy. The tool incorporated serology (measuring antibodies to tissue transglutaminase) and stratifying patients according to their referral symptoms (patients were classified as having a “high risk” or “low risk” of coeliac disease). The decision tool was then tested on a second cohort of patients attending for gastroscopy. In the second cohort all patients had a routine duodenal biopsy and serology performed. Setting Teaching hospital in Sheffield. Participants 2000 consecutive adult patients referred for gastroscopy recruited prospectively. Main outcome measure Evaluation of a clinical decision tool using patients' referral symptoms, tissue transglutaminase antibody results, and duodenal biopsy results. Results No cases of coeliac disease were missed by the pre-endoscopy testing algorithm. The prevalence of coeliac disease in patients attending for endoscopy was 3.9% (77/2000, 95% confidence interval 3.1% to 4.8%). The prevalence in the high risk and low risk groups was 9.6% (71/739, 7.7% to 12.0%) and 0.5% (6/1261, 0.2% to 1.0%). The prevalence of coeliac disease in patients who were negative for tissue transglutaminase antibody was 0.4% (7/2000). The sensitivity, specificity, positive predictive value, and negative predictive value for a positive antibody result to diagnose coeliac disease was 90.9%, 90.9%, 28.6%, and 99.6%, respectively. Evaluation of the clinical decision tool gave a sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 60.8%, 9.3%, and 100%, respectively. Conclusions Pre-endoscopy serological testing in combination with biopsy of high risk cases detected all cases of coeliac disease. The use of this decision tool may enable the endoscopist to target patients who need a duodenal biopsy.

13 September 2007 in BMJ
Verified
Journal Article
Closed access
PDF file
AHAndrew D Hopper
Andrew D Hopper
MHMarios Hadjivassiliou
Marios Hadjivassiliou
SBSohail Butt
Sohail Butt
DSDavid S Sanders
David S Sanders
#### Summary points The prevalence of coeliac disease is 0.5-1% in international population studies. The delay in diagnosis is reported to range from 4.5 years to 9.0 years.1 2 Patients may present on numerous occasions to both primary and secondary care without coeliac disease being considered.3 Currently, for every adult patient in whom the disease is diagnosed, eight cases are estimated to go undetected.4 Coeliac disease (or gluten sensitive enteropathy) is defined as a state of heightened immunological responsiveness to ingested gluten (from wheat, barley, or rye) in genetically susceptible individuals. Coeliac disease has historically been considered to be an uncommon gastrointestinal condition. In addition, most clinicians expect to recognise infant or childhood presentations with overt symptoms of malabsorption (or failure to thrive). A paradigm shift has occurred, however, in our conceptual understanding of coeliac disease. Recent international studies assessing the prevalence of coeliac disease in the general population have consistently reported that coeliac disease affects 0.5-1% of all adults.w1 Adult presentations are now more frequent than paediatric (a ratio of 9:1, according to the 2005 membership data of the Coeliac UK charity). Patients most commonly present during their 40s.w2 Patients with adult coeliac disease rarely present with symptoms suggestive of malabsorption (low body mass index accounts for 5% of all cases diagnosed, with most having either a normal or overweight body mass indexw3). Far more commonly they describe non-specific or subtle gastrointestinal symptoms (for example, non-specific abdominal pain, symptoms similar …

1 February 2007 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PDF file
AHA.D. Hopper
A.D. Hopper
RSR. Sidhu
R. Sidhu
DHD.P. Hurlstone
D.P. Hurlstone
MMM.E. McAlindon
M.E. McAlindon
DSD.S. Sanders
D.S. Sanders

1 November 2006 in Digestive and Liver Disease
Verified
Journal Article
Closed access
AHA.D. Hopper
A.D. Hopper
DHD.P. Hurlstone
D.P. Hurlstone
JLJ.S. Leeds
J.S. Leeds
MMM.E. McAlindon
M.E. McAlindon
ADA.K. Dube
A.K. Dube
DSD.S. Sanders
D.S. Sanders

1 February 2009 in Clinical Medicine
Verified
Journal Article
Open access
PDF file
AHAndrew D Hopper
Andrew D Hopper
RARobert J Atkinson
Robert J Atkinson
ARAdam Razak
Adam Razak
ARAshrafur Rahim
Ashrafur Rahim
APAnisha Perera
Anisha Perera
DSDavid S Sanders
David S Sanders
A number of reports have suggested that academic medicine within the UK may be in decline. This article assesses the number and outcome of abstracts presented at consecutive British Society of Gastroenterology (BSG) meetings. All abstracts presented at the BSG between 1994 and 2002 were assessed (n=4,096). Full publication rates of abstracts were then compared between meetings. Other abstract characteristics were also analysed. There was a significant downward trend demonstrated for the percentage of abstracts going onto full publication (p=0.02). In 1994, 57.6% of abstracts were subsequently fully published but by 2002 this number had fallen to 30.7%. The results show that the number of abstracts at the BSG which are then fully published has fallen with a significant trend. This observation could be taken as an indicator that there is a decline in research activity within the UK gastroenterology community.